Forced inspiratory volume in one second (FIV1 ) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002
The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Source: Eur Respir J 2003; 21: 95-10 Year: 2003
Forced expiratory volume in one second (FEV1 ) and peak expiratory flow (PEF): is there a correlation in chronic obstructive pulmonary disease (COPD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Hoover‘s sign predicts expiratory flow limitation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002
FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007
Does rapid decline predict poor prognosis? Source: Annual Congress 2007 - Rapid decline in lung function and its consequences Year: 2007
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Is Hoover‘s sign helpful to detect expiratory flow limitation in chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
How can time to COPD exacerbation be delayed? A real-world study comparing two oscillating positive expiratory pressure (OPEP) devices in patients with chronic obstructive pulmonary disease (COPD) or chronic bronchitis Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Population surveillance in North West Adelaide: lung function and chronic obstructive pulmonary disease (COPD) across the diabetes spectrum Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005
The effect of tiotropium on exacerbations and airflow in patients with COPD Source: Eur Respir J 2006; 27: 547-555 Year: 2006
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006
The effect of pulmonary rehabilitation on expiratory flow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007
Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=281 Year: 2006
Inspiratory capacity-to-total lung capacity ratio is related to expiratory flow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Lung function I Year: 2007
Incidence and time course of expiratory flow limitation (FL) in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 172s Year: 2006
The effect of pulmonary rehabilitation toward expiratory airflow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Airways mechanics in different applications Year: 2010